FDA, it will be a major
milestone in the history of
this effort and should help
to further accelerate IRD
research and development.
Success will beget success.
And none of this would be happening without the
sustained, focused efforts of FFB’s Board, National
Trustees, volunteer leaders, and donors over the
past 46 years.
What has made those accomplishments
Teamwork and sustained effort are the two
biggest contributing factors. First and foremost,
none of these research advances would have been
possible without the sustained support of FFB’s
generous donors. Second, the relationships FFB
has forged with the research community and
with biotech and pharmaceuticals partners have
pushed the research forward. I also think FFB’s
willingness to invest in early research and its
strategy of investing in research that could lead
to treatments across retinal degenerative diseases
were wise decisions and have paid off.
On a more personal note — who are your
heroes in this field and why?
My heroes are all the amazing individuals and
families I’ve met over the past 12 years who are
so committed to this mission and who persevere
through the challenges of vision loss daily with
high spirits and optimism. The stories from this
community of tremendous accomplishments
despite significant obstacles are so inspirational
and, frankly, humbling. I feel so lucky to have
been a part of it and to
have had a chance to
meet so many inspiring
people. I also must say that
Gordon and Lulie are also
my heroes. The leadership
and support they have provided is, I believe,
without precedent in the history of disease
What’s next for FFB and what’s next for you?
I have no doubt that FFB is on the right road to
finding cures for retinal degenerative diseases. The
progress made over the last 10 years is remarkable
and will allow the pace of research and discovery
to get even faster. We use a tag line in a lot of our
information material — “A Cure Is Within Sight”
— it’s true!
As for me, I will take all that I’ve learned as
FFB’s CEO to my next position — wherever that
may be. In a nutshell, I’ll depart with firsthand
knowledge of what can be accomplished when an
organization is committed to making sustained
investments in science in order to help people.
...I’ll depart with firsthand
knowledge of what can
be accomplished when an
organization is committed
to making sustained
investments in science in
order to help people. ”